Funding announcement
Investment Manager, Main Sequence Ventures · angel in 1 deal
Alezeia Brown
Roles
Disclosed deals
Every published round Alezeia Brown took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Andromeda | Series A | 9 Sep 2025 | $23m | Participant | Startup Daily (24 Aug 2026), Galileo Ventures, Startup Daily (9 Sep 2025), Women's Agenda, SmartCompany, Main Sequence Ventures portfolio, Purpose Ventures portfolio |
Portfolio
Companies Alezeia Brown has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Andromeda | Personalised robot companions for aged care and assisted living | 9 Sep 2025, Series A | 1 | 0 |
Funds
Fund closes reported for Alezeia Brown, as distinct from the investments it has made.
Portfolio companies acquired
Companies Alezeia Brown has backed that another company then bought. An exit for the holding, not a deal Alezeia Brown did.
Coverage
Stories naming Alezeia Brown. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding announcement
QIC partners with Main Sequence in local VC push
QVCDF money is going into Main Sequence to fund Queensland deep tech investing; the state government's extra $55 million takes the program to $130 million.
Funding announcement
Queensland government backs 5 VCs, including Antler and Main Sequence, with $130 million
Queensland's government is committing $130 million across five venture firms — Antler, Five V Capital, Main Sequence, Mandalay and Salus — via a new fund to widen early-stage funding for local startups.
Key hire
What makes a great venture partner?
Main Sequence announces Gabrielle Munzer's promotion to its first Partner, tracing her journey from capital markets through Senior Associate and Principal roles and the signals the firm values in venture partners.
Key hire
Main Sequence announces new Partner, Gabrielle Munzer, to build companies with biology
Australia's Main Sequence fund promotes Gabrielle Munzer to Partner to lead its biotech push; the article also covers her finance background, the firm's company-building model, a UNSW accelerator, and recent diverse hires.